Palvella Therapeutics PVLA Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Palvella Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Palvella Therapeutics's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Palvella Therapeutics's current ratio?
- Palvella Therapeutics (PVLA) reported current ratio of 28.9× in Q1 2026.
- How has Palvella Therapeutics's current ratio changed year-over-year?
- Palvella Therapeutics's current ratio increased by 226.6% year-over-year, from 8.8× to 28.9×.
- What is the long-term trend for Palvella Therapeutics's current ratio?
- Over 5 years (2020 to 2025), Palvella Therapeutics's current ratio has grown at a 8.7% compound annual growth rate (CAGR), from 3.4× to 5.2×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.